"Adenosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
| Descriptor ID |
D000241
|
| MeSH Number(s) |
D03.633.100.759.590.138 D13.570.583.138 D13.570.800.096
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenosine".
Below are MeSH descriptors whose meaning is more specific than "Adenosine".
This graph shows the total number of publications written about "Adenosine" by people in this website by year, and whether "Adenosine" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 10 | 5 | 15 |
| 1996 | 13 | 6 | 19 |
| 1997 | 13 | 7 | 20 |
| 1998 | 6 | 8 | 14 |
| 1999 | 6 | 10 | 16 |
| 2000 | 10 | 4 | 14 |
| 2001 | 6 | 10 | 16 |
| 2002 | 6 | 6 | 12 |
| 2003 | 16 | 9 | 25 |
| 2004 | 14 | 9 | 23 |
| 2005 | 5 | 3 | 8 |
| 2006 | 11 | 6 | 17 |
| 2007 | 12 | 11 | 23 |
| 2008 | 7 | 7 | 14 |
| 2009 | 11 | 14 | 25 |
| 2010 | 8 | 6 | 14 |
| 2011 | 12 | 8 | 20 |
| 2012 | 7 | 10 | 17 |
| 2013 | 6 | 10 | 16 |
| 2014 | 9 | 9 | 18 |
| 2015 | 11 | 6 | 17 |
| 2016 | 11 | 11 | 22 |
| 2017 | 5 | 12 | 17 |
| 2018 | 10 | 7 | 17 |
| 2019 | 8 | 8 | 16 |
| 2020 | 5 | 7 | 12 |
| 2021 | 12 | 9 | 21 |
| 2022 | 6 | 13 | 19 |
| 2023 | 1 | 10 | 11 |
| 2024 | 4 | 11 | 15 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Adenosine" by people in Profiles.
-
En masse evaluation of RNA guides (EMERGe) for ADARs. Methods Enzymol. 2025; 710:131-152.
-
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature. 2025 Jan; 637(8048):1207-1217.
-
The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma. Cancer Discov. 2024 Nov 01; 14(11):2279-2299.
-
Duration of adenosine-induced myocardial hyperaemia: insights from quantitative 13N-ammonia positron emission tomography myocardial perfusion imaging. Eur Heart J Cardiovasc Imaging. 2024 Sep 30; 25(10):1367-1373.
-
Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5'-GA Sites. Biomolecules. 2024 Sep 29; 14(10).
-
Open label clinical trial of orally administered molnupiravir as a first-line treatment for naturally occurring effusive feline infectious peritonitis. J Vet Intern Med. 2024 Nov-Dec; 38(6):3087-3094.
-
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice. Antimicrob Agents Chemother. 2024 Oct 08; 68(10):e0103924.
-
RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection. PLoS One. 2024; 19(8):e0307450.
-
Site-specific regulation of RNA editing with ribose-modified nucleoside analogs in ADAR guide strands. Nucleic Acids Res. 2024 Jul 08; 52(12):6733-6747.
-
A quest for novel antimicrobial targets: Inhibition of Asp-tRNAAsn/Glu-tRNAGln amidotransferase (GatCAB) by synthetic analogs of aminoacyl-adenosine in vitro and live bacteria. Bioorg Chem. 2024 09; 150:107530.